Risk of hepatitis B virus reactivation in patients treated with anti-TNFα agents for immune-mediated inflammatory diseases R. Pereira, I. Raposo, F. Nery, T. Torres

Virus Reactivation With Eosinophilia and Systemic Symptoms: An Imitator of Immune Reconstitution Inflammatory Syndrome With an Excellent Clinical Response to Valganciclovir H.A. Ramírez-Marín, J.G. Domínguez-Cherit

Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases E. Vilarrasa, J. Nicolau, P. de la Cueva, A. Goday, F. Gallardo, A. Martorell-Calatayud, J.M. Carrascosa